Statistical Trends in Pharmaceutical Research for Poor Countries

Peter Lanjouw () and Jean Lanjouw

Working Papers from eSocialSciences

Abstract: Introducing patent rights in developing country markets might stimulate greater R and D investment targeting their specific health needs – areas long neglected. This paper examines this argument using statistical data and survey evidence. We identify a set of diseases where 99 per cent of the burden is estimated to fall in lower income countries. Because science gaps and market potential will influence R and D priorities, this group is broke into a subset that already have low-cost and effect treatments, and those that to not.

Keywords: R and D; investment; health; statistical data; survey; diseases; burden; lower income countries; science; market potential; low cost; treatments; Pharmaceutical Research; poor countries; innovative; India; R&D; developing drugs; drugs (search for similar items in EconPapers)
Date: 2009-11
New Economics Papers: this item is included in nep-cwa, nep-hea, nep-ino, nep-ipr and nep-pr~
Note: Institutional Papers
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.esocialsciences.org/Download/repecDownl ... &AId=2308&fref=repec

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ess:wpaper:id:2308

Access Statistics for this paper

More papers in Working Papers from eSocialSciences
Bibliographic data for series maintained by Padma Prakash ().